Researchers at Stanford University Report Findings in Managed Care (What is Medicare Advantage and Why is it the Most Important Contemporary Policy Affecting Kidney Disease?): Managed Care

2025 DEC 02 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Data detailed on Managed Care have been presented. According to news reporting out of Stanford, California, by NewsRx editors, research stated, “Medicare Advantage (MA) enrollment among patients receiving dialysis has surged following the 21 Century Cures Act, which lifted prior restrictions on enrollment. As MA becomes the plurality payer for dialysis, understanding its implications for patients, providers, and policymakers is critical.”

Our news journalists obtained a quote from the research from Stanford University, “MA offers out-of-pocket spending caps and additional services not covered under fee-for-service (FFS) Medicare. Some plans also prioritize care coordination, which may improve patient outcomes. However, concerns remain regarding limited provider networks, prior authorization barriers, and disparities in access to medications and transplants. The increasing shift to MA also challenges value-based care models, as most quality measures and payment models for patients receiving dialysis are limited to FFS Medicare. Although research examining the benefits and downsides of MA is paramount, comparing MA and FFS Medicare is complicated by selection bias and incomplete or inaccessible data.”

According to the news editors, the research concluded: “To ensure that increasing enrollment into MA has not harmed patients, policymakers must enhance data fidelity and transparency, strengthen regulatory oversight, and align financial incentives across populations to safeguard access to high-quality care for patients receiving dialysis.”

This research has been peer-reviewed.

For more information on this research see: What is Medicare Advantage and Why is it the Most Important Contemporary Policy Affecting Kidney Disease? American Journal of Kidney Diseases, 2025. American Journal of Kidney Diseases can be contacted at: W B Saunders Co-elsevier Inc, 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, USA. (Elsevier - www.elsevier.com; American Journal of Kidney Diseases - http://www.journals.elsevier.com/american-journal-of-kidney-diseases/)

Our news journalists report that additional information may be obtained by contacting Jillian S. Caldwell, Stanford University, School of Medicine, Division of Nephrology, Stanford, CA.

Publisher contact information for the American Journal of Kidney Diseases is: W B Saunders Co-elsevier Inc, 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, USA.

(Our reports deliver fact-based news of research and discoveries from around the world.)